← All trials
NCT02575131
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2015
- Primary completion
- Dec 31, 2015
- Completion date
- Jul 31, 2016
- First posted
- Oct 14, 2015
- Last posted
- Oct 19, 2016
- Enrollment
- 32
- Arms / groups
- 10 / —
- Source
- AACT · ctgov ingestion
Sponsors
- TNOLead sponsor
- Nederlands Bakkerij CentrumCollaborator
- PepsiCoCollaborator
- TNOOverall official - principal investigator
- TNOReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.